| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $250.3M | +11.9% |
| R&D Expense | $6.5M | +364.3% |
| SG&A Expense | $43.4M | -0.1% |
| Operating Income | -$949K | -475.2% |
| Pre-tax Income | -$61.0M | -158.7% |
| Income Tax | $2.1M | +90.1% |
| Net Income | -$63.2M | -155.5% |
| EPS (Basic) | -$0.59 | -2850.0% |
| EPS (Diluted) | -$0.59 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $391.2M | +589.3% |
| Accounts Receivable | $27.0M | -44.7% |
| Inventory | $10.7M | -26.3% |
| Current Assets | $447.6M | +213.7% |
| Total Assets | $1.71B | +85.0% |
| Current Liabilities | $141.5M | -19.6% |
| Long-term Debt | $511.4M | +41.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $439.2M | +490.8% |
| Investing Cash Flow | -$260.6M | -48.4% |
| Financing Cash Flow | $157.2M | +25.0% |
| -2850.0% |
| Total Liabilities |
| $1.35B |
| +147.8% |
| Stockholders' Equity | $358.9M | -5.3% |